# The Efficacy of Empagliflozin on Kidney Functions in Lupus Nephritis Population

> **NCT07700940** · PHASE4 · RECRUITING · sponsor: **Ahmed Yehia Ismail** · enrollment: 66 (estimated)

## Conditions studied

- Lupus Nephritis (LN)

## Interventions

- **DRUG:** Empagliflozin (25 Mg Tab) along with standard medical therapy
- **DRUG:** Placebo and standard of care

## Key facts

- **NCT ID:** NCT07700940
- **Lead sponsor:** Ahmed Yehia Ismail
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-22
- **Primary completion:** 2026-12-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2026-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07700940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07700940, "The Efficacy of Empagliflozin on Kidney Functions in Lupus Nephritis Population". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07700940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*